249 related articles for article (PubMed ID: 26880366)
1. Landmark estimation of survival and treatment effects in observational studies.
Parast L; Griffin BA
Lifetime Data Anal; 2017 Apr; 23(2):161-182. PubMed ID: 26880366
[TBL] [Abstract][Full Text] [Related]
2. Landmark Estimation of Survival and Treatment Effect in a Randomized Clinical Trial.
Parast L; Tian L; Cai T
J Am Stat Assoc; 2014 Jan; 109(505):384-394. PubMed ID: 24659838
[TBL] [Abstract][Full Text] [Related]
3. The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes.
Austin PC; Stuart EA
Stat Methods Med Res; 2017 Aug; 26(4):1654-1670. PubMed ID: 25934643
[TBL] [Abstract][Full Text] [Related]
4. Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.
Díaz I; Colantuoni E; Hanley DF; Rosenblum M
Lifetime Data Anal; 2019 Jul; 25(3):439-468. PubMed ID: 29492746
[TBL] [Abstract][Full Text] [Related]
5. Bias-adjusted Kaplan-Meier survival curves for marginal treatment effect in observational studies.
Wang X; Bai F; Pang H; George SL
J Biopharm Stat; 2019; 29(4):592-605. PubMed ID: 31286838
[TBL] [Abstract][Full Text] [Related]
6. Statistical power in parallel group point exposure studies with time-to-event outcomes: an empirical comparison of the performance of randomized controlled trials and the inverse probability of treatment weighting (IPTW) approach.
Austin PC; Schuster T; Platt RW
BMC Med Res Methodol; 2015 Oct; 15():87. PubMed ID: 26472109
[TBL] [Abstract][Full Text] [Related]
7. On variance estimation of the inverse probability-of-treatment weighting estimator: A tutorial for different types of propensity score weights.
Kostouraki A; Hajage D; Rachet B; Williamson EJ; Chauvet G; Belot A; Leyrat C
Stat Med; 2024 Jun; 43(13):2672-2694. PubMed ID: 38622063
[TBL] [Abstract][Full Text] [Related]
8. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
Kawahara T; Shinozaki T; Matsuyama Y
BMC Med Res Methodol; 2020 Jul; 20(1):204. PubMed ID: 32736528
[TBL] [Abstract][Full Text] [Related]
9. The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.
Fukuda M; Sakamaki K; Oba K
Clin Trials; 2023 Dec; 20(6):670-680. PubMed ID: 37455538
[TBL] [Abstract][Full Text] [Related]
10. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
Willems S; Schat A; van Noorden MS; Fiocco M
Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
[TBL] [Abstract][Full Text] [Related]
11. Survival analysis using auxiliary variables via non-parametric multiple imputation.
Hsu CH; Taylor JM; Murray S; Commenges D
Stat Med; 2006 Oct; 25(20):3503-17. PubMed ID: 16345047
[TBL] [Abstract][Full Text] [Related]
12. Causal inference in survival analysis using longitudinal observational data: Sequential trials and marginal structural models.
Keogh RH; Gran JM; Seaman SR; Davies G; Vansteelandt S
Stat Med; 2023 Jun; 42(13):2191-2225. PubMed ID: 37086186
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of inverse probability weighting using the propensity score for baseline covariate adjustment in smaller population randomised controlled trials with a continuous outcome.
Raad H; Cornelius V; Chan S; Williamson E; Cro S
BMC Med Res Methodol; 2020 Mar; 20(1):70. PubMed ID: 32293286
[TBL] [Abstract][Full Text] [Related]
14. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.
Latimer NR; Abrams KR; Siebert U
BMC Med Res Methodol; 2019 Mar; 19(1):69. PubMed ID: 30935369
[TBL] [Abstract][Full Text] [Related]
15. Doubly Robust and Efficient Estimation of Marginal Structural Models for the Hazard Function.
Zheng W; Petersen M; van der Laan MJ
Int J Biostat; 2016 May; 12(1):233-52. PubMed ID: 27227723
[TBL] [Abstract][Full Text] [Related]
16. Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias.
Howe CJ; Cole SR; Chmiel JS; Muñoz A
Am J Epidemiol; 2011 Mar; 173(5):569-77. PubMed ID: 21289029
[TBL] [Abstract][Full Text] [Related]
17. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis.
Austin PC
Stat Med; 2016 Dec; 35(30):5642-5655. PubMed ID: 27549016
[TBL] [Abstract][Full Text] [Related]
18. Robust methods to improve efficiency and reduce bias in estimating survival curves in randomized clinical trials.
Zhang M
Lifetime Data Anal; 2015 Jan; 21(1):119-37. PubMed ID: 24522498
[TBL] [Abstract][Full Text] [Related]
19. Selection Bias Due to Loss to Follow Up in Cohort Studies.
Howe CJ; Cole SR; Lau B; Napravnik S; Eron JJ
Epidemiology; 2016 Jan; 27(1):91-7. PubMed ID: 26484424
[TBL] [Abstract][Full Text] [Related]
20. Joint modeling of concurrent binary outcomes in a longitudinal observational study using inverse probability of treatment weighting for treatment effect estimation.
Agogo GO; Murphy TE; McAvay GJ; Allore HG
Ann Epidemiol; 2019 Jul; 35():53-58. PubMed ID: 31085069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
